Vance J. Plumb

TL;DR: For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual-chamber pacing offers no clinical advantage over ventricular backup pacing and may be detrimental by increasing the combined end point of death or hospitalization for heart failure.

TL;DR: An irregular sequence of RR intervals produces adverse hemodynamic consequences that are independent of heart rate, and is compared with VVI pacing at the same average rate.

TL;DR: Radiofrequency ablation of the slow AV pathway is highly effective and is associated with low rate of complications, and the late development of complete AV block in another patient after fast pathway ablation.

TL;DR: The primary analysis, arrhythmia event rate during the first 48 hours of therapy, showed comparable efficacy between the bretylium and intravenous amiodarone, the only approved class III antiarrhythmic agent.

TL;DR: In this paper, 27 consecutive patients with VAs originating from the left ventricle (LV) summit were studied, and the authors found that the most superior portion of the epicardial LV bounded by an arc from left anterior descending coronary artery, superior to the first septal perforating branch to the left circumflex coronary artery may present challenges for catheter ablation.